Autologous stem-cell transplantation after second-line brentuximab vedotin in relapsed or refractory Hodgkin lymphoma
Titel:
Autologous stem-cell transplantation after second-line brentuximab vedotin in relapsed or refractory Hodgkin lymphoma
Auteur:
Herrera, A.F. Palmer, J. Martin, P. Armenian, S. Tsai, N.-C. Kennedy, N. Sahebi, F. Cao, T. Budde, L.E. Mei, M. Siddiqi, T. Popplewell, L. Rosen, S.T. Kwak, L.W. Nademanee, A. Forman, S.J. Chen, R.